Please use this identifier to cite or link to this item: https://doi.org/10.1038/s41598-018-35096-x
DC FieldValue
dc.titleTear Proteins Calcium binding protein A4 (S100A4) and Prolactin Induced Protein (PIP) are Potential Biomarkers for Thyroid Eye Disease
dc.contributor.authorChng, C.-L
dc.contributor.authorSeah, L.L
dc.contributor.authorYang, M
dc.contributor.authorShen, S.Y
dc.contributor.authorKoh, S.K
dc.contributor.authorGao, Y
dc.contributor.authorDeng, L
dc.contributor.authorTong, L
dc.contributor.authorBeuerman, R.W
dc.contributor.authorZhou, L
dc.date.accessioned2020-10-20T09:38:32Z
dc.date.available2020-10-20T09:38:32Z
dc.date.issued2018
dc.identifier.citationChng, C.-L, Seah, L.L, Yang, M, Shen, S.Y, Koh, S.K, Gao, Y, Deng, L, Tong, L, Beuerman, R.W, Zhou, L (2018). Tear Proteins Calcium binding protein A4 (S100A4) and Prolactin Induced Protein (PIP) are Potential Biomarkers for Thyroid Eye Disease. Scientific Reports 8 (1) : 16936. ScholarBank@NUS Repository. https://doi.org/10.1038/s41598-018-35096-x
dc.identifier.issn2045-2322
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/178382
dc.description.abstractThere are no reliable biomarkers to predict thyroid eye disease (TED) in patients with autoimmune thyroid disease (AITD) currently. Several evidences support the involvement of the lacrimal gland in TED. The aim of our study was to quantitatively correlate the changes in tear protein profile with increasing severity of TED. Tear samples were collected from four groups of patients; AITD without TED (AITD), AITD with mild TED (mild TED), AITD with severe TED (severe TED) and normal controls. A total of 72 patients were recruited for the study. In discovery phase, isobaric tags for relative and absolute quantification (iTRAQ) 4-plex was used for quantitative proteomics analysis. For verification of results from discovery phase, sequential window acquisition of all theoretical fragment ion spectra (SWATH) was used to analyze an independent cohort from normal controls, AITD, mild TED and severe TED. Two proteins, S100A4 and PIP showed consistent dysregulation trends in the discovery and validation phase experiments. Our study demonstrated the differences in tear proteome across the spectrum of different severity and activity of TED in patients with AITD. Two tear proteins, S100A4 and PIP may serve as potential biomarkers to predict progression to severe TED in patients with AITD. © 2018, The Author(s).
dc.publisherNature Publishing Group
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjectbiological marker
dc.subjectcalvasculin
dc.subjectcarrier protein
dc.subjecteye protein
dc.subjectglycoprotein
dc.subjectPIP protein, human
dc.subjectS100A4 protein, human
dc.subjecttear proteins
dc.subjectendocrine ophthalmopathy
dc.subjecthuman
dc.subjectmetabolism
dc.subjectmetabolome
dc.subjectmetabolomics
dc.subjectprocedures
dc.subjectBiomarkers
dc.subjectCarrier Proteins
dc.subjectEye Proteins
dc.subjectGlycoproteins
dc.subjectGraves Ophthalmopathy
dc.subjectHumans
dc.subjectMetabolome
dc.subjectMetabolomics
dc.subjectS100 Calcium-Binding Protein A4
dc.typeArticle
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.contributor.departmentOPHTHALMOLOGY
dc.description.doi10.1038/s41598-018-35096-x
dc.description.sourcetitleScientific Reports
dc.description.volume8
dc.description.issue1
dc.description.page16936
dc.published.statepublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_s41598-018-35096-x.pdf1.21 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons